Deena Horn
Foot & Ankle Surgery · New York, NYNPI 1376806877
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by Royal Biologics, Inc. at 24.4% of the total. 2025 is the largest year on record at $31,697, 3.0 times the $10,473 reported in 2019. Among foot & ankle surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 276 payments — averaging $335.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Royal Biologics, Inc.$23K
- Novastep Inc.$21K
- Medline Industries LP$19K
- Trilliant Surgical LLC.$9K
- Medshape, Inc.$6K
- Polynovo North America LLC$3K
- plus $12K from 32 others
What the payments were for
- Consulting fees$53,45858%
- Speaking & faculty fees$8,4009%
- Travel & lodging$14,23415%
- Food & beverage$15,22116%
- Education$1,1621%
- Gifts$320%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Royal Biologics, Inc. | 25 | $22,549 |
| Novastep Inc. | 22 | $21,127 |
| Medline Industries LP | 39 | $19,451 |
| Trilliant Surgical LLC. | 12 | $8,941 |
| Medshape, Inc. | 10 | $5,920 |
| Polynovo North America LLC | 39 | $2,857 |
| In2bones USA, LLC | 4 | $2,515 |
| Stryker | 12 | $1,445 |
| Gotham Surgical Solutions & Devices, Inc. | 1 | $1,162 |
| Smith+Nephew | 43 | $967 |
| Organogenesis Inc. | 18 | $856 |
| Acera Surgical, Inc. | 7 | $852 |
| Musculoskeletal Transplant Foundation Inc. | 3 | $828 |
| Orthofix Medical, Inc. | 6 | $463 |
| Integra Lifesciences Corporation | 3 | $353 |
| Nevro Corp. | 2 | $315 |
| Gramercy Extremity Orthopedics LLC | 1 | $267 |
| Linvatec Corporation | 2 | $255 |
| Arteriocyte Medical Systems, Inc. | 1 | $241 |
| Suvon Surgical LLC | 1 | $158 |
| Cook Medical LLC | 2 | $133 |
| Cagent Vascular Inc | 1 | $130 |
| Polarityte, Inc. | 1 | $103 |
| Fusion Orthopedics USA, LLC | 1 | $87 |
| Acell, Inc. | 3 | $72 |
| DJO, LLC | 2 | $63 |
| Next Science LLC | 2 | $61 |
| Access Pro Medical, LLC | 1 | $48 |
| Medtronic | 1 | $47 |
| Solventum Corporation | 2 | $47 |
| AbbVie | 2 | $42 |
| Globus Medical | 1 | $33 |
| Avita Medical Americas, LLC | 1 | $31 |
| Aroa Biosurgery Incorporated | 1 | $27 |
| Dynasplint Systems Inc. | 1 | $17 |
| Bioventus LLC | 1 | $16 |
| Teleflex LLC | 1 | $16 |
| Paratek Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MEDLINE UNITE$33,454
- NEXIS$25,847
- MEDLINE$16,836
- MEDLINE INDUSTRIES, INC.$8,418
- PENDING$8,418
- MJFS4536$7,298
- Arsenal Ankle$6,869
- Arsenal Sinus Support Plate$5,277
- AIRLOCK CENTROLOCK$4,939
- DynaNail$4,208
- CoLag Screws$2,800
- CoLink$2,515
- Novosorb BTM$2,278
- PECA Bunion Correction System$2,265
- CoLink MTP Plate$2,000
- Neospan Staples$2,000
- Minimally Invasive Bunion Plate, Left$1,780
- INTEGRA$840
- CoLink 5MS System$800
- Alloaid PIP$800
How this compares
$92,506 in reported general payments places this provider in the 95th percentile of 652 foot & ankle surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 49 | $15,167 |
| Ammonium Lactate | 160 | $3,466 |
| CiclopiroxCiclopirox Olamine | 150 | $2,385 |
| Ciclopirox | 42 | $1,247 |
| Gabapentin | 42 | $691 |
| Terbinafine Hcl | 42 | $629 |
| Pregabalin | 12 | $552 |
| Clotrimazole | 13 | $435 |
| Diclofenac Sodium | 49 | $359 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 37 | $325 |
| Mupirocin | 29 | $196 |
| Triamcinolone Acetonide | 22 | $74 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $74 |
| Tramadol Hcl | 14 | $53 |
| Oxycodone Hcl | 12 | $47 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $967 | $15,16749 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 652 foot & ankle surgery providers in New York.
Other foot & ankle surgery in New York
- Jonathan DelandNew York$4M
- Constantine DemetracopoulosNew York$888K
- Anne JohnsonNew York$815K
- Scott EllisNew York$597K
- John KennedyNew York$534K
- Stuart MogulNew York$131K
- John DoolanNew York$87K
- Jason SnyderNew York$79K
- Meghan KellyNew York$75K
- Matthew ContiNew York$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.